Nutritional Support as Part of Comprehensive Care for Palliative Patients With Cancer: A Review

Cover Page

Cite item

Full Text

Abstract

The role of nutritional support in incurable patients with cancer remains a topic of ongoing debate. However, clinical guidelines on palliative care recommend evaluating nutritional deficits, as fasting worsens functional status and quality of life, leads to unplanned hospitalizations, and decreases survival.

This review presents current data on the management of anorexia–cachexia syndrome as part of comprehensive palliative care. The literature search was conducted using the Scientific Electronic Library (eLIBRARY.RU) and PubMed, limited to publications from 2000 to 2024.

Based on our analysis, the necessity of individualized nutritional support has been identified as a key component of cachexia management aimed at improving quality of life. When oral intake is insufficient, initial measures include consultations with dietitians and other specialists, along with management of dyspeptic symptoms. If these measures prove ineffective, sip feeding and home enteral tube feeding are indicated. The effectiveness of pharmacological methods for managing cancer anorexia–cachexia syndrome remains a matter of debate. The need for prescribed therapeutic exercise as a measure to prevent the progression of sarcopenia is also actively discussed.

Thus, although the management of cancer anorexia–cachexia syndrome in palliative care is primarily symptomatic, individualized nutritional support combined with limited physical activity and symptom-directed therapy can improve the quality of life in palliative patients with cancer.

About the authors

Olga A. Obukhova

Blokhin National Medical Research Center of Oncology

Author for correspondence.
Email: obukhova0404@yandex.ru
ORCID iD: 0000-0003-0197-7721
SPIN-code: 6876-7701

MD, Cand. Sci. (Medicine)

Russian Federation, 24 Kashirskoe shosse, Moscow, 115522

Ildar A. Kurmukov

Blokhin National Medical Research Center of Oncology

Email: kurmukovia@gmail.com
ORCID iD: 0000-0001-8463-2600
SPIN-code: 3692-5202

MD, Cand. Sci. (Medicine)

Russian Federation, 24 Kashirskoe shosse, Moscow, 115522

Grigory S. Yunaev

Blokhin National Medical Research Center of Oncology

Email: garik_dr@mail.ru
ORCID iD: 0000-0002-9562-9113
SPIN-code: 4410-8937
Russian Federation, 24 Kashirskoe shosse, Moscow, 115522

References

  1. Kaprin AD, Starinskii VV, Shakhzadova AO. Malignant neoplasms in Russia in 2019 [Internet]. Moscow: Herzen Moscow Oncology Research Institute; 2020. Available from: https://oncology-association.ru/wp-content/uploads/2021/10/zabol.-i-smertn.-2019-elektr.versiya.pdf
  2. Obukhova OA, Kurmukov IA, Semenova AA, et al. Nutritional deficiency in patients with newly diagnosed diffuse large B-cell lymphoma. Prevalence and approaches to correction. Oncohematology. 2024;19(3)233–242. doi: 10.17650/1818-8346-2024-19-3-233-242 EDN: RUTLZP
  3. Gameeva EV, Stepanova AM, Kostin AA. Effects of nutritional support carried out during drug-based antitumor treatment of oncological patients. Head and Neck Tumors. 2021;11(4):50–57. doi: 10.17650/2222-1468-2021-11-4-50-57 EDN: HDJJTG
  4. Peixoto da Silva S, Santos JMO, Costa E Silva MP, et al. Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle. 2020;11(3):619–635. doi: 10.1002/jcsm.12528 EDN: UNMXOM
  5. Dequae CGR, Raber-Durlacher JE, Epstein JB, et al. Taste alterations after hematopoietic cell transplantation: a scoping review. Support Care Cancer. 2024;32(10):687. doi: 10.1007/s00520-024-08900-w EDN: BZVMQK
  6. Zygulska AL, Furgala A, Krzemieniecki K, et al. Association between gastric myoelectric activity disturbances and dyspeptic symptoms in gastrointestinal cancer patients. Adv Med Sci. 2019;64(1):44–53. doi: 10.1016/j.advms.2018.08.004
  7. Kawasaki Y, Kakimoto K, Tanaka Y, et al. Relationship between chemotherapy-induced diarrhea and Y. intestinal microbiome composition. Digestion. 2023;104(5):357–369. doi: 10.1159/000528282
  8. Di Mattei VE, Perego G, Milano F, Gatti F. The Effectiveness of Nonpharmacological Interventions in the Management of Chemotherapy Physical Side Effects: A Systematic Review. Healthcare (Basel). 2024;12(18):1880. doi: 10.3390/healthcare12181880 EDN: EKWCMQ
  9. Beloborodova AV, Nevzorova DV, Sizova ZhM, Bakunina EA. Assessment and management of gastrointestinal distressing symptoms in adult patients receiving palliative care. Bulletin of Anesthesiology and Reanimatology. 2017;14(6):73–78. doi: 10.21292/2078-5658-2017-14-6-73-78 EDN: CRMPZT
  10. Tradounsky GE. Gastro-intestinal symptoms in palliative care patients. Curr Oncol. 2024;31(4):2341–2352. doi: 10.3390/curroncol31040174 EDN: UNJRNB
  11. Hart NH, Crawford-Williams F, Crichton M, et al. Unmet supportive care needs of people with advanced cancer and their caregivers: A systematic scoping review. Crit Rev Oncol Hematol. 2022;176:103728. doi: 10.1016/j.critrevonc.2022.103728 EDN: WYLFMO
  12. Ivanova AS, Obukhova OA, Markovich AA, Titova TA. Prevalence of anxiety and depressive disorders in patients with neuroendocrine neoplasia receiving drug treatment. Issues of oncology. 2023;69(3S):396–397. EDN: WRGHIY
  13. Ivanova AS, Obukhova OA, Kurmukov IA, Wolf LYa. Review of ESPEN-2021 practical recommendations for cancer patients. Part 2: specific issues of nutritional support. Clinical nutrition and metabolism. 2022;3(4):193–206. doi: 10.17816/clinutr119059 EDN: TKPXSS
  14. Vladimirova LYu, Gladkov OA, Koroleva IA, et al. Nausea and vomiting. RUSSCO practical recommendations, part 2. Malignant tumors. 2024;14(3s2):32–47. doi: 10.18027/2224-5057-2024-14-3s2-2-02 EDN: AJSHGX
  15. Osetrova OV, Sidorov AV, Nevzorova DV. Pharmacotherapy of emetic syndrome in adult patients requiring palliative care. Pallium: palliative and hospice care. 2021;2(11):4–10. EDN: JGREWO
  16. Hardy J, Davis MP. The management of nausea and vomiting not related to anticancer therapy in patients with cancer. Curr Treat Options Oncol. 2021;22(2):17. doi: 10.1007/s11864-020-00813-0
  17. Šoukalová Z. Olanzapine in oncology palliative care. Klin Onkol. 2022;35(4):276-283. doi: 10.48095/ccko2022276 EDN: NLIVBD
  18. Wickham RJ. Nausea and Vomiting: a palliative care imperative. Curr Oncol Rep. 2020;22(1):1. doi: 10.1007/s11912-020-0871-6
  19. Wickham RJ. Nausea and vomiting not related to cancer therapy: intractable problem or clinical challenge? J Adv Pract Oncol. 2020;11(5):476–488. doi: 10.6004/jadpro.2020.11.5.4
  20. Davis M, Hui D, Davies A, et al. MASCC antiemetics in advanced cancer updated guideline. Support Care Cancer. 2021;29(12):8097–8107. doi: 10.1007/s00520-021-06437-w. EDN: HJJBMI
  21. Star A, Boland JW. Updates in palliative care — recent advancements in the pharmacological management of symptoms. Clin Med. 2018;18:11–16. doi: 10.7861/clinmedicine.18-1-11
  22. Gade AR, Kang M, Khan F, et al. Enhanced sensitivity of alpha3beta4 nicotinic receptors in enteric neurons after long-term morphine: implication for opioid-induced constipation. J Pharmacol Exp Ther. 2016;357(3):520–528. doi: 10.1124/jpet.116.233304
  23. Hisanaga T, Shinjo T, Imai K, et al. Clinical guidelines for management of gastrointestinal symptoms in cancer patients: the Japanese society of palliative medicine recommendations. Journal of Palliative Medicine. 2019;22(8):986-997. doi: 10.1089/jpm.2018.0595
  24. Lazebnik B, Sarsenbaeva AS, Avalueva EB, et al. Clinical guidelines «Chronic diarrhea in adults». Experimental and clinical gastroenterology. 2021;188(4):7–67. doi: 10.31146/1682-8658-ecg-188-4-7-67
  25. Ivanova AS, Obukhova OA, Kurmukov IA, Wolf LYa. Review of ESPEN-2021 practical recommendations for cancer patients. Part 1. Clinical nutrition and metabolism. 2022;3(3):140–152. doi: 10.17816/clinutr111900 EDN: YLUOMT
  26. Dev R, Amano K, Naito T, Del Fabbro E. Anamorelin for the treatment of cancer anorexia-cachexia syndrome. Curr Oncol Rep. 2024;26(7):762–772. doi: 10.1007/s11912-024-01549-y EDN: KRWOXO
  27. Groarke JD, Crawford J, Collins SM, et al. Ponsegromab for the treatment of cancer cachexia. N Engl J Med. 2024;391(24):2291–2303. doi: 10.1056/NEJMoa2409515 EDN: TQSCSF
  28. Chowdhury IH, Rahman MS, Chowdhury MNK, et al. Mirtazapine versus megestrol acetate in treatment of anorexia-cachexia in advanced cancer patients: a randomized, double-blind trial. Jpn J Clin Oncol. 2024;54(5):530–536. doi: 10.1093/jjco/hyae009 EDN: BIVJSE
  29. Andrade C. Therapeutic effects, side effects, and adverse effects of neuropsychiatric drugs in the context of treating cancer-related anorexia with olanzapine and mirtazapine. J Clin Psychiatry. 2024;85(3):24f15532. doi: 10.4088/JCP.24f15532 EDN: PZLDLC
  30. Amano K, Baracos VE, Hopkinson JB. Integration of palliative, supportive, and nutritional care to alleviate eating-related distress among advanced cancer patients with cachexia and their family members. Crit Rev Oncol Hematol. 2019;143:117–123. doi: 10.1016/j.critrevonc.2019.08.006
  31. Constantina C, Mary E, George O, et al. Nonpharmacological management of cancer-related cachexia: a systematic review. Semin Oncol Nurs. 2025;41(1):151803. doi: 10.1016/j.soncn.2024.151803
  32. O’Donoghue A, Barrett M, Dhuibhir PU, et al. Taste and smell abnormalities in advanced cancer: Negative impact on subjective food intake. Nutr Clin Pract. 2023;38(4):807-816. doi: 10.1002/ncp.10943 EDN: AQTLAP
  33. Mercadante S, Aielli F, Adile C, et al. Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients. Support Care Cancer. 2015;23(11):3249–3255. doi: 10.1007/s00520-015-2720-y. EDN: HEYGWC
  34. Ha SI, Kim K, Kim JS. The influence of symptoms on quality of life among patients who have undergone oesophageal cancer surgery. Eur J Oncol Nurs. 2016;24:13–19. doi: 10.1016/j.ejon.2016.08.002
  35. Mohapatra S, Santharaman A, Gomez K, et al. Optimal Management of Dysphagia in Patients with Inoperable Esophageal Cancer: Current Perspectives. Cancer Manag Res. 2022;14:3281–3291. doi: 10.2147/CMAR.S362666 EDN: VIZSIQ
  36. J Ly, O’Grady G, Mittal A, et al. A systematic review of methods to palliate malignant gastric outlet obstruction. Surg Endosc. 2010;24(2):290–297. doi: 10.1007/s00464-009-0577-1 EDN: LUJRUH
  37. Amano K, Maeda I, Morita T, et al. Eating-related distress and need for nutritional support of families of advanced cancer patients: a nationwide survey of bereaved family members. J Cachexia Sarcopenia Muscle. 2016;7(5):527–534. doi: 10.1002/jcsm.12102
  38. Hopkinson JB. Food connections: a qualitative exploratory study of weight- and eating-related distress in families affected by advanced cancer. Eur J Oncol Nurs. 2016;20:87–96. doi: 10.1016/j.ejon.2015.06.002
  39. Koshimoto S, Arimoto M, Saitou K, et al. Need and demand for nutritional counselling and their association with quality of life, nutritional status and eating-related distress among patients with cancer receiving outpatient chemotherapy: a cross-sectional study. Support Care Cancer. 2019;27(9):3385–3394. doi: 10.1007/s00520-018-4628-9 EDN: GACBMS
  40. Nasrah R, Van Der Borch C, Kanbalian M, Jagoe RT. Defining barriers to implementation of nutritional advice in patients with cachexia. J Cachexia Sarcopenia Muscle. 2020;11(1):69–78. doi: 10.1002/jcsm.12490
  41. Maschke J, Kruk U, Kastrati K, et al. Nutritional care of cancer patients: a survey on patients’ needs and medical care in reality. Int J Clin Oncol. 2017;22(1):200–206. doi: 10.1007/s10147-016-1025-6. EDN: OBDHFH
  42. Ueshima J, Nagano A, Maeda K, et al. Nutritional counseling for patients with incurable cancer: Systematic review and meta-analysis. Clin Nutr. 2023;42(2):227–234. doi: 10.1016/j.clnu.2022.12.013 EDN: UHLXWW
  43. Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition — A consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1–9. doi: 10.1016/j.clnu.2018.08.002
  44. Del Olmo-García M, Hernandez-Rienda L, Garcia-Carbonero R, et al. Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) study. Oncologist. 2025;30(2):oyae343. doi: 10.1093/oncolo/oyae343
  45. Barrea L, Altieri B, Muscogiuri G, et al. Impact of nutritional status on gastroenteropancreatic neuroendocrine tumors (GEP-NET) aggressiveness. Nutrients. 2018;10(12):1854. doi: 10.3390/nu10121854
  46. Mcluskie A, Bowers M, Bayly J, et al. Nutritional interventions in randomised clinical trials for people with incurable solid cancer: A systematic review. Clin Nutr. 2025:44:201–219. doi: 10.1016/j.clnu.2024.12.008
  47. Blackwood HA, Hall CC, Balstad TR, et al. A systematic review examining nutrition support interventions in patients with incurable cancer. Support Care Cancer. 2020;28(4):1877–1889. doi: 10.1007/s00520-019-04999-4 EDN: LMVSSO
  48. Manikhas GM, Luft VM, Dreval RO, et al. The influence of therapeutic enteral nutrition on the quality of life of cancer patients in need of palliative care. Oncology. Journal im. P.A. Herzen. 2022;11(2):33–39. doi: 10.17116/onkolog20221102133
  49. Petrova OM, Lipatov ON, Kudryashova LN. Symptomatic therapy against the background of correction of protein-energy malnutrition in patients with generalized forms of gastrointestinal cancer. Creative surgery and oncology. 2022;12(4):288–294. doi: 10.24060/2076-3093-2022-12-4-288-294 EDN: YTQAHH
  50. Gancev ShKh, Kamilov FKh, Kudryashova LN, et al. Correction of nutritional status using omega-3 fatty acids in patients with common forms of digestive organ cancer. Creative surgery and oncology. 2011;3:19-25. EDN: ZSHFDB
  51. Ruggeri E, Giannantonio M, Agostini F, et al. Home artificial nutrition in palliative care cancer patients: Impact on survival and performance status. Clin Nutr. 2020;39(11):3346–3353. doi: 10.1016/j.clnu.2020.02.021 EDN: NRUHGJ
  52. Amano K, Maeda I, Ishiki H, et al. Effects of enteral nutrition and parenteral nutrition on survival in patients with advanced cancer cachexia: Analysis of a multicenter prospective cohort study. Clin Nutr. 2021;40(3):1168–1175. doi: 10.1016/j.clnu.2020.07.027 EDN: QAIDVX
  53. Hall CC, Skipworth RJE, Blackwood H, et al. A randomized, feasibility trial of an exercise and nutrition-based rehabilitation programme (ENeRgy) in people with cancer. J Cachexia Sarcopenia Muscle. 2021(6):2034–2044. doi: 10.1002/jcsm.12806 EDN: MHPIXL
  54. Haug M, Schwappacher R, Pollmann C, et al. Effects of adjuvant exercise and nutrition therapy on muscle fibre biomechanics in gastrointestinal cancer patients. Cancers (Basel). 2024;16(8):1608. doi: 10.3390/cancers16081608 EDN: GEFZIK
  55. Uster A, Ruehlin M, Mey S, et al. Effects of nutrition and physical exercise intervention in palliative cancer patients: A randomized controlled trial. Clin Nutr. 2018;37(4):1202–1209. doi: 10.1016/j.clnu.2017.05.027
  56. Boullata JI, Carrera AL, Harvey L, et al. ASPEN safe practices for enteral nutrition therapy. J Parenter Enter Nutr. 2017;41:15–103. doi: 10.1177/0148607116673053
  57. Kamal AH, Bausewein C, Casarett DJ, et al. Standards, guidelines, and quality measures for successful specialty palliative care integration into oncology: current approaches and future directions. J Clin Oncol. 2020;38(9):987–994. doi: 10.1200/JCO.18.02440 EDN: XDCNGN
  58. Nevzorova DV, Sidorov AV, Morev AV, et al. Clinical efficacy of a specialized product for tube feeding with arginine, zinc and antioxidants compared with standard tube feeding in the complex treatment of pressure ulcers: an open randomized study in parallel groups with a low level of intervention in real practice. Russian Neurological Journal. 2024;29(5):62–72. doi: 10.30629/2658-7947-2024-29-5-62-72
  59. De Vries YC, Boesveldt S, Kampman E, et al. Low reported taste function is associated with low preference for high protein products in advanced oesophagogastric cancer patients undergoing palliative chemotherapy. Clin Nutr. 2019;38(1):472–475. doi: 10.1016/j.clnu.2017.12.001
  60. Luft VM, Lapitsky AV, Sergeeva AM, Kelbetova BR. Enteral nutrition in palliative medicine: pharmaconutrient characteristics and possibilities of differentiated use of enteral nutritional mixtures. Pallium: palliative and hospice care. 2022;4(17):47–53. EDN: ICIVXB
  61. Bischoff SC, Austin P, Boeykens K, et al. ESPEN practical guideline: Home enteral nutrition. Clin Nutr. 2022;41(2):468–488. doi: 10.1016/j.clnu.2021.10.018 EDN: XCMMUS
  62. Abu-Hilal M, Hemandas AK, McPhail M, et al. A comparative analysis of safety and efficacy of different methods of tube placement for enteral feeding following major pancreatic resection. A non-randomized study. Jop. 2010;11:8e13.
  63. Han-Geurts IJM, Hop WC, Verhoef C, et al. Randomized clinical trial comparing feeding jejunostomy with nasoduodenal tube placement in patients undergoing oesophagectomy. Br J Surg. 2007;94(1):31–35. doi: 10.1002/bjs.5283
  64. Koshel AP, Mosolkov VYu. Areflux jejunostomy in surgery of tumor stenosis of the esophagus. Siberian Oncological Journal. 2009;3:30–35. EDN: KWKLTR
  65. Pironi L, Boeykens K, Bozzetti F, et al. ESPEN practical guideline: Home parenteral nutrition. Clin Nutr. 2023;42(3):411–430. doi: 10.1016/j.clnu.2022.12.003 EDN: TUDFUA
  66. Bering J, DiBaise JK. Home Parenteral and Enteral Nutrition. Nutrients. 2022;14(13):2558. doi: 10.3390/nu14132558 EDN: YXOKEU
  67. Gamzaeva MI, Goldman OE, Tokarev SG. Psychosocial needs of palliative patients and their relatives: analysis of calls to patient assistance hotlines. Pallium: palliative and hospice care. 2023;20(3):38–48. EDN: DKJIFR
  68. Goodrose-Flores C, Schedin A, Nelander J, et al. High-protein compared with standard parenteral nutrition in palliative cancer care. BMJ Support Palliat Care. 2022;12(3):332–338. doi: 10.1136/bmjspcare-2019-002139 EDN: IXUIDG
  69. Vashi PG, Dahlk S, Popiel B, et al. A longitudinal study investigating quality of life and nutritional outcomes in advanced cancer patients receiving home parenteral nutrition. BMC Cancer. 2014;14:593. doi: 10.1186/1471-2407-14-593 EDN: NRGCSL
  70. Cotogni P, Monge T, Passera R, et al. Clinical characteristics and predictive factors of survival of 761 cancer patients on home parenteral nutrition: A prospective, cohort study. Cancer Med. 2020;9(13):4686–4698. doi: 10.1002/cam4.3064 EDN: CXEHGQ
  71. Nevzorova DV, Luft VM, Leiderman IN, et al. Nutrition support and rehydration of adults in need of palliative care. Methodical recommendations. [Internet]. Moscow; 2021. Режим доступа: https://pro-palliativ.ru/library/items/nutritivnayapodderzhka-i-regidratatsionnaya-terapiya-u-vzroslykh-patsientov.
  72. Naghibi M, Skinner C, Burden ST, et al. A multi-national survey of experience and attitudes towards commencing home parenteral nutrition for patients with advanced cancer. Clin Nutr ESPEN. 2022:47:246–251. doi: 10.1016/j.clnesp.2021.12.002 EDN: TZRNEG
  73. Batu Z, Maraş GB, Turan K. Enhancing nutritional care in palliative care units: assessing nurse knowledge and quality perception in enteral nutrition practices. BMC Nurs. 2024;23(1):949. doi: 10.1186/s12912-024-02580-x EDN: VGAIGJ
  74. Bullock AF, Greenley SL, Patterson MJ, et al. Patient, family and carer experiences of nutritional screening: a systematic review. J Hum Nutr Diet. 2021;34(3):595–603. doi: 10.1111/jhn.12849 EDN: DLJRFX
  75. Boulanger A, Chabal T, Fichaux M, et al. Opinions about the new law on end-of-life issues in a sample of french patients receiving palliative care. BMC Palliat Care. 2017;16(1):7. doi: 10.1186/s12904-016-0174-8 EDN: ECCQBD
  76. Obukhova OA, Snegovoy AV, Kurmukov IA, et al. Nutritional status of cancer patients before antitumor treatment: a single-center prospective observational study. Clinical nutrition and metabolism. 2020;1(4):178–189. doi: 10.17816/clinutr64707 EDN: NIOWHL

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».